6+ hour, 46+ min ago  (194+ words) UK biotech Nucleome Therapeutics has appointed Dr Michelle Morrow as chief scientific officer, as it pushes ahead with a pipeline aimed at the molecular roots of inflammatory disease. Dr Morrow joins from Avacta Therapeutics (AIM: AVCT), where she served as…...